Menu
No results found.
688016
Shanghai MicroPort Endovascular MedTech Co., Ltd. – SHA
Weekly Share Price & Valuation Overview
Market Overview
Open
112.2200
Close
118.1700
High
120.5700
Low
111.6700
Trend
0.46140
Shanghai MicroPort Endovascular MedTech Co., Ltd.
China
• SHA - Shanghai Stock Exchange
• 688016
• Currency: CNY
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company's products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People's Republic of China.
Key strengths
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
Potential weaknesses
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CNY 14.55B
- Enterprise Value Operating value: market cap + total debt − cash.
- CNY 12.37B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CNY 1.18B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CNY 833.32M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CNY 489.68M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CNY 9.56
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 3.62
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 1.70%
- Shares Outstanding
- 123.26M
- Float Shares
- 70.55M
- Implied Shares Outstanding
- 123.26M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
42.58%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
41.48%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
70.59%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
37.90%
- ROA Return on assets: net income ÷ total assets.
-
6.29%
- ROE Return on equity: net income ÷ shareholder equity.
-
10.99%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Year-over-year revenue growth.
-
-7.20%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-30.00%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-29.70%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 5.68
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.04
- Total Cash Cash and equivalents.
- CNY 2.15B
- Total Debt Short + long-term interest-bearing debt.
- CNY 160.65M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- CNY -1.99B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 0.33
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CNY 201.68M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- CNY -244.92M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
17.09%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-20.75%
- Cash Conversion (OpCF/EBITDA)
- 0.41
Sharemaestro House View
Confidence: 1
Sharemaestro internal conviction (0–3, higher is better).
Risk: 3
Sharemaestro internal risk profile (0–3, higher is safer).
Operational: 1
Operational quality/consistency (0–3, higher is better).
Composite Score: 2
Overall internal composite (0–3, higher is better).
Suggested Allocation: 3.33%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
57.2%
Insiders
Shares held by company insiders (officers, directors).
41.8%
Institutions
Shares held by institutions (funds, pensions).
10.6%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
CNY -1.99B
-168.2% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
77
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:10
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.